Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer

Recruiting now

Conditions studied: Cervix Cancer, HPV-Related Malignancy

In brief

In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma, Adeno-squamous carcinoma or AIS we want to examine prospectively: 1. Examine if negative HR-HPV after conization to the HR-HPV the women had before conization has a high prognostic value for no residual tumor in the final pathology. 2. To examine if conization in women with cervical tumor up to Stage I B 2 (FIGO 2018) is corelated with better prognosis.

Key facts

Study ID

NCT06196190

Run by

Rambam Health Care Campus

People needed

200

Starts

2023-07-26

Expected to finish

2028-07-01

Last updated by the study team

2024-01-09

Who can join

Age: 18 and older, up to 85. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age Range: 18-85 years old Cervical cancer stage I B 2(Tumor up to 4 cm FIGO 2018) AIS HPV types before and after conization

You may not qualify if…

• Pregnant women under 18 years old. Women who refused to continue to be in study. Women that data about HPV types , final pathology or complication are missing.

Where it is running

• Rambam Health Care Center — Haifa, Israel (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.